Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,595,947
-$871,674 QoQ
Shares Held
6,284
-37.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#2,538
of 4,664 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EARNED WEALTH ADVISORS, LLC holds $8,347,145 across 10 Drug Manufacturers - General names. JNJ ranks #2 (19.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,314 | $2,775,481 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
6,284 | $1,595,947 | |
| 3 | ABBV |
AbbVie Inc.
|
5,103 | $1,284,118 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
7,324 | $925,314 | |
| 5 | MRK |
Merck & Co., Inc.
|
3,294 | $423,279 | |
| 6 | PFE |
Pfizer Inc
|
15,837 | $381,354 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,515 | $260,154 | |
| 8 | AZN |
Astrazeneca PLC
|
1,288 | $244,230 |
All Filings in JNJ
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,595,947 | 6,284 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,467,621 | 10,095 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,908,906 | 9,224 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $872,771 | 4,707 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $728,923 | 4,772 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $1,303,336 | 7,859 | Shares | Sole | 2025-05-09 | |
| 2024-09-30 | $317,799 | 1,961 | Shares | Sole | 2024-11-01 | |
| No filing history on record for this holder in this stock. | ||||||